213 related articles for article (PubMed ID: 6684595)
1. Mechanism of cisplatin nephrotoxicity.
Weiner MW; Jacobs C
Fed Proc; 1983 Oct; 42(13):2974-8. PubMed ID: 6684595
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of cis-platinum nephrotoxicity: I. Effects of sulfhydryl groups in rat kidneys.
Levi J; Jacobs C; Kalman SM; McTigue M; Weiner MW
J Pharmacol Exp Ther; 1980 Jun; 213(3):545-50. PubMed ID: 7193725
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin nephrotoxicity: experimental and clinical studies.
Daugaard G
Dan Med Bull; 1990 Feb; 37(1):1-12. PubMed ID: 2178884
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations.
Dobyan DC; Levi J; Jacobs C; Kosek J; Weiner MW
J Pharmacol Exp Ther; 1980 Jun; 213(3):551-6. PubMed ID: 7193726
[TBL] [Abstract][Full Text] [Related]
5. Renal handling of cis-diamminedichloroplatinum(II).
Jacobs C; Kalman SM; Tretton M; Weiner MW
Cancer Treat Rep; 1980; 64(12):1223-6. PubMed ID: 7193518
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of O-(beta-hydroxyethyl)-rutoside on cis-platinum-induced acute renal failure in the rat.
Dobyan DC; Bull JM; Strebel FR; Sunderland BA; Bulger RE
Lab Invest; 1986 Nov; 55(5):557-63. PubMed ID: 3773477
[TBL] [Abstract][Full Text] [Related]
7. Effects of cis-diamminedichloroplatinum(II) on rabbit kidney in vivo and on rabbit renal proximal tubule cells in culture.
Tay LK; Bregman CL; Masters BA; Williams PD
Cancer Res; 1988 May; 48(9):2538-43. PubMed ID: 2965614
[TBL] [Abstract][Full Text] [Related]
8. Acute and chronic cisplatin nephropathy in rats.
Choie DD; Longnecker DS; del Campo AA
Lab Invest; 1981 May; 44(5):397-402. PubMed ID: 7194946
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cis-diamminedichloroplatinum secretion by the human kidney with probenecid.
Jacobs C; Coleman CN; Rich L; Hirst K; Weiner MW
Cancer Res; 1984 Aug; 44(8):3632-5. PubMed ID: 6540140
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the mechanisms of renal damages induced by nephrotoxic compounds].
Yamada T
Nihon Hoigaku Zasshi; 1995 Dec; 49(6):447-57. PubMed ID: 8583688
[TBL] [Abstract][Full Text] [Related]
11. Long-term consequences of cis-platinum-induced renal injury: a structural and functional study.
Dobyan DC
Anat Rec; 1985 Jul; 212(3):239-45. PubMed ID: 4061878
[TBL] [Abstract][Full Text] [Related]
12. Cis-diamminedichloroplatinum (II)-induced acute renal failure in the rat. Correlation of structural and functional alterations.
Jones TW; Chopra S; Kaufman JS; Flamenbaum W; Trump BF
Lab Invest; 1985 Apr; 52(4):363-74. PubMed ID: 4039014
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
14. Necrosis of the pars recta (S3 segment) of the rat kidney produced by hexachloro 1:3 butadiene.
Ishmael J; Pratt I; Lock EA
J Pathol; 1982 Oct; 138(2):99-113. PubMed ID: 7131132
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the possible role of iron and copper in cisplatin-induced nephrotoxicity in the rat.
Goudie J; Chandra M; Lawrence GD; Williams P
Res Commun Chem Pathol Pharmacol; 1994 Jan; 83(1):33-49. PubMed ID: 8165368
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of concomitant administration of imatinib on cisplatin-induced nephrotoxicity focusing on renal organic cation transporter OCT2.
Tanihara Y; Masuda S; Katsura T; Inui K
Biochem Pharmacol; 2009 Nov; 78(9):1263-71. PubMed ID: 19540211
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of organic cation transport inhibitors on cis-diamminedichloroplatinum-induced nephrotoxicity.
Bird JE; Walser MM; Quebbemann AJ
J Pharmacol Exp Ther; 1984 Dec; 231(3):752-8. PubMed ID: 6542140
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
[TBL] [Abstract][Full Text] [Related]
20. Reduction of cisplatin nephrotoxicity by procainamide: does the formation of a cisplatin-procainamide complex play a role?
Viale M; Vannozzi MO; Pastrone I; Mariggiò MA; Zicca A; Cadoni A; Cafaggi S; Tolino G; Lunardi G; Civalleri D; Lindup WE; Esposito M
J Pharmacol Exp Ther; 2000 Jun; 293(3):829-36. PubMed ID: 10869382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
